Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of darvadstrocel (Cx601) for complex perianal fistulas in Crohn's disease (Japan)
jRCT1080224084Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of darvadstrocel in Crohn's disease, sponsored by Takeda. Primary endpoint: Combined remission at Week 24. Started Oct 2018; status: completed.
02
Drugs
darvadstrocel
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on jRCT1080224084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224084.